Review Article
/ VOLUME 1, ISSUE 3, DECEMBER 2019
Rare Yeasts: Emerging Threat in Immunocompromised Patients
Infections of the yeasts other than Candida spp. are rare, but an emerging clinical entity. Clinicians should be alert for early diagnosis. Early distinction of non-Candida yeasts is important because of varying antifungal susceptibilities, higher mortality of 50-80% particularly among immunocompromised patients. These yeasts include Basidiomycetes […] Read More